DyeVert™ PLUS EZ system for Preventing Contrast-Induced Acute Kidney Injury in Patients Undergoing Diagnostic Coronary Angiography and/or Percutaneous Coronary Intervention: A UK-Based Cost-Utility Analysis

Mehdi Javanbakht, Mohsen Rezaei Hemami, Atefeh Mashayekhi, Michael Branagan-Harris
doi: https://doi.org/10.1101/19008185

Article Information

doi 
https://doi.org/10.1101/19008185
History 
  • October 8, 2019.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Mehdi Javanbakht1,3,*,
  2. Mohsen Rezaei Hemami2,
  3. Atefeh Mashayekhi1,3 and
  4. Michael Branagan-Harris3
  1. 1Optimax Access UK Ltd, Market Access Consultancy, UK
  2. 2PenTAG Health Technology Assessment, University of Exeter, Exeter, UK
  3. 3Device Access UK Ltd, Market Access Consultancy, University of Southampton Science Park, Chilworth Hampshire, UK
  1. ↵*Corresponding Author
    : Mehdi Javanbakht (MSc, PhD) Mailing Address: Device Access UK Ltd, Kenneth Dibben House, Enterprise Rd, Chilworth, Southampton Science Park, Southampton SO16 7NS, UK, Telephone Number: 00441914351081, E-Mail Address: HEOR{at}deviceaccess.co.uk

  1. Author contributions: Mehdi Javanbakht was responsible for developing and populating the economic model and drafting the first draft of the manuscript. All authors provided inputs for the model, read, and approved the final draft of the manuscript.

Back to top
Posted October 08, 2019.
Download PDF
Data/Code
Email
DyeVert™ PLUS EZ system for Preventing Contrast-Induced Acute Kidney Injury in Patients Undergoing Diagnostic Coronary Angiography and/or Percutaneous Coronary Intervention: A UK-Based Cost-Utility Analysis
Mehdi Javanbakht, Mohsen Rezaei Hemami, Atefeh Mashayekhi, Michael Branagan-Harris
medRxiv 19008185; doi: https://doi.org/10.1101/19008185
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area